DCB29 is a selective inhibitor of the BPTF bromodomain, with an IC50 value of 13.2 µM. DCB29 can be used for the study of the treatment of BPTF-related diseases (such as bladder cancer, colorectal cancer, melanoma, leukemia, and other cancers)[1].
Molecular Weight:
321.11
CAS Number:
[723245-31-6]
Formula:
C10H12INO3
Target:
Epigenetic Reader Domain
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
